This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9189313

PUBLISHED SUBJECT

Aquisição de Medicamentos do Foro Oncologico ao abrigo do AQ 2021/06

Parties involved

Place of performance
Portugal, Setúbal, Santiago do Cacém
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
NOVARTIS FARMA-PRODUT.FARMACEUTICOS, SA · Tax ID 500063524
Bidder
ASTRAZENECA PRODUTOS FARMAC., LDA · Tax ID 502942240
Bidder
ROCHE FARMACEUTICA QUIMICA, LDA · Tax ID 500233810
Bidder
LEO FARMACEUTICOS, LDA · Tax ID 503932680
Bidder
Generis Farmacêutica, SA · Tax ID 508107997
Bidder
ACCORD HEALTHCARE, UNIPESSOAL, LDA · Tax ID 508622263
Bidder
FRESENIUS KABI PHARMA PORTUGAL, LDA. · Tax ID 504293753

Values and timeline

Contract price
€35,304.00
Procedure base price
€377,106.99
Total effective price
Not reported on Portal BASE
Publication date
19 April 2022
Award date
13 April 2022
Signing date
14 April 2022
Performance period
270 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Monofator
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement
CP 2021/6 - Medicamentos do foro oncológico e imunomoduladores
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
5827631

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts